Anti-CRP Antibody Market is a critical segment of the in-vitro diagnostics (IVD) market, used in immunoassays for measuring C-reactive protein (CRP) levels, a key biomarker for inflammation and infection. High-sensitivity CRP (hs-CRP) tests are also used for assessing cardiovascular risk. The market is driven by the high volume of CRP testing in clinical laboratories.The market is seeing a trend towards the development of highly specific monoclonal antibodies for use in point-of-care (POC) and high-throughput automated analyzers. Key players include Roche, Abbott, and Siemens Healthineers. With the wide clinical utility of CRP in guiding antibiotic therapy and monitoring chronic inflammatory diseases, the demand for reliable anti-CRP antibodies remains strong and stable.
Other Related Reports:www.wiseguyreports.com/reports/bloodless-castrator-market
www.wiseguyreports.com/reports/enteric-coating-market
www.wiseguyreports.com/reports/cochlear-implants-for-adults-market
www.wiseguyreports.com/reports/prefilled-heparin-flush-syringes-market
www.wiseguyreports.com/reports/stent-assisted-coiling-market
www.wiseguyreports.com/reports/aciclovir-eye-drop-market
www.wiseguyreports.com/reports/insulin-injection-pump-market
www.wiseguyreports.com/reports/luciferase-assay-system-market